Repositorio Dspace

Postmortem genetic testing in sudden death: clinical and medico-legal implications

Mostrar el registro sencillo del ítem

dc.contributor.author Sabater-Molina, María
dc.contributor.author Nicolás-Rocamora, Elisa
dc.contributor.author Munteanu, Serena
dc.contributor.author Fuentes-Bermejo, María-Dolores
dc.contributor.author Osuna-Carrillo-Albornoz, Eduardo
dc.contributor.author Pérez-Cárceles, María-Dolores
dc.contributor.author Pastor-Quirante, Francisco
dc.contributor.author Gimeno-Blanes, Juan-Ramón
dc.contributor.author Hernández-del-Rincón, Juan-Pedro
dc.date.accessioned 2026-08-03T10:29:04Z
dc.date.available 2026-08-03T10:29:04Z
dc.date.issued 2026-05-08
dc.identifier.issn 0937-9827
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/27203
dc.description.abstract BACKGROUND: Anatomopathological autopsy and postmortem genetic testing play a crucial role in forensic medicine, particularly in elucidating the causes of sudden death (SD) that remain unexplained by conventional methods. This study explores their value in detecting inherited cardiac conditions with medico-legal and preventive implications. METHODS: From a 15-year forensic cohort, 12 cases of sudden unexpected death in which conventional autopsy was inconclusive or where a hereditary cardiac condition was suspected, were analyzed. Each case underwent histology, toxicology, and targeted next-generation sequencing panels covering genes associated with channelopathies and cardiomyopathies. Variants were classified according to ACMG/AMP guidelines, and family studies were performed when feasible. RESULTS: Integrated pathological and genetic analysis identified pathogenic or likely pathogenic variants in several cases, notably in RYR2 and CALM2 (channelopathies) and FLNC and PPP1R13L (cardiomyopathies). In these cases, genetic findings confirmed the diagnosis, while variants of uncertain significance were detected in others. Postmortem genetic testing proved essential in cases with structurally normal hearts or sub-diagnostic findings, such as concealed arrhythmogenic cardiomyopathy. Familial cascade testing uncovered additional carriers, enabling targeted surveillance and preventive measures. CONCLUSION: Combining pathological autopsy and postmortem genetic testing significantly improves the diagnostic yield in unexplained SD, uncovers hidden hereditary cardiac conditions, and provides critical information for risk assessment in relatives. Beyond clinical implications, these findings contribute to accurate forensic determinations and prevention of miscarriages of justice. Integrating genetic studies into forensic protocols should become standard practice to ensure both scientific rigor and legal fairness. CLINICAL TRIAL REGISTRATION: Not applicable.
dc.language.iso eng
dc.publisher SPRINGER
dc.rights Atribución/Reconocimiento 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.title Postmortem genetic testing in sudden death: clinical and medico-legal implications
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 42098522
dc.relation.publisherversion https://link.springer.com/10.1007/s00414-026-03771-8
dc.type.version info:eu-repo/semantics/publishedVersion 
dc.identifier.doi 10.1007/s00414-026-03771-8
dc.journal.title INTERNATIONAL JOURNAL OF LEGAL MEDICINE
dc.identifier.essn 1437-1596


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta